TATT vs. BMRN
TATT (Tat Techno) and BMRN (BioMarin Pharmaceutical Inc.) are both stocks. TATT operates in Aerospace & Defense (Industrials), while BMRN operates in Biotechnology (Healthcare). Over the past 10 years, TATT returned 20.56%/yr vs -4.86%/yr for BMRN. At a 0.08 correlation, their price movements are largely independent.
Performance
TATT vs. BMRN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TATT achieves a -4.12% return, which is significantly higher than BMRN's -8.03% return. Over the past 10 years, TATT has outperformed BMRN with an annualized return of 20.56%, while BMRN has yielded a comparatively lower -4.86% annualized return.
TATT
- 1D
- 6.10%
- 1M
- 22.48%
- YTD
- -4.12%
- 6M
- 6.49%
- 1Y
- 60.71%
- 3Y*
- 86.27%
- 5Y*
- 49.10%
- 10Y*
- 20.56%
BMRN
- 1D
- 2.51%
- 1M
- -1.44%
- YTD
- -8.03%
- 6M
- 0.64%
- 1Y
- -3.75%
- 3Y*
- -16.34%
- 5Y*
- -6.84%
- 10Y*
- -4.86%
TATT vs. BMRN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TATT Tat Techno | -4.12% | 73.91% | 153.00% | 91.51% | -16.00% | 39.28% | -10.30% | -17.89% | -41.43% | 23.44% |
BMRN BioMarin Pharmaceutical Inc. | -8.03% | -9.58% | -31.83% | -6.83% | 17.14% | 0.75% | 3.71% | -0.70% | -4.51% | 7.64% |
Correlation
The correlation between TATT and BMRN is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jul 27, 1999 | 0.08 |
Fundamentals
TATT:
$565.41M
BMRN:
$10.80B
TATT:
$1.29
BMRN:
$1.37
TATT:
33.30
BMRN:
39.85
TATT:
0.25
BMRN:
2.39
TATT:
3.09
BMRN:
3.30
TATT:
3.13
BMRN:
1.74
TATT:
$177.02M
BMRN:
$3.24B
TATT:
$44.18M
BMRN:
$2.46B
TATT:
$22.13M
BMRN:
$439.56M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TATT vs. BMRN — Risk / Return Rank
TATT
BMRN
TATT vs. BMRN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tat Techno (TATT) and BioMarin Pharmaceutical Inc. (BMRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TATT | BMRN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.10 | ||
| Sortino ratioReturn per unit of downside risk | +1.51 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.01 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 1.28 | -0.17 | +1.45 |
| Martin ratioReturn relative to average drawdown | 3.41 | -0.35 | +3.76 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TATT | BMRN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.99 | -0.11 | +1.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.93 | -0.21 | +1.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.42 | -0.14 | +0.55 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.08 | 0.11 | -0.03 |
Drawdowns
TATT vs. BMRN - Drawdown Comparison
The maximum TATT drawdown since its inception was -97.07%, which is greater than BMRN's maximum drawdown of -90.58%. Use the drawdown chart below to compare losses from any high point for TATT and BMRN.
Loading charts...
Drawdown Indicators
| TATT | BMRN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.07% | -90.58% | -6.49% |
Max Drawdown (1Y)Largest decline over 1 year | -47.50% | -22.49% | -25.01% |
Max Drawdown (3Y)Largest decline over 3 years | -47.50% | -49.83% | +2.33% |
Max Drawdown (5Y)Largest decline over 5 years | -47.50% | -57.64% | +10.14% |
Max Drawdown (10Y)Largest decline over 10 years | -75.11% | -62.09% | -13.02% |
Current DrawdownCurrent decline from peak | -29.92% | -63.35% | +33.43% |
Average DrawdownAverage peak-to-trough decline | -66.05% | -45.51% | -20.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.83% | 10.84% | +6.99% |
Volatility
TATT vs. BMRN - Volatility Comparison
Tat Techno (TATT) has a higher volatility of 25.05% compared to BioMarin Pharmaceutical Inc. (BMRN) at 15.30%. This indicates that TATT's price experiences larger fluctuations and is considered to be riskier than BMRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TATT | BMRN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.05% | 15.30% | +9.75% |
Volatility (6M)Calculated over the trailing 6-month period | 48.04% | 27.79% | +20.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.66% | 34.57% | +27.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.89% | 32.87% | +20.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.52% | 35.51% | +14.01% |
Dividends
TATT vs. BMRN - Dividend Comparison
Neither TATT nor BMRN has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
BMRN BioMarin Pharmaceutical Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TATT Tat Techno | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.24% | 3.88% |
Financials
TATT vs. BMRN - Financials Comparison
This section allows you to compare key financial metrics between Tat Techno and BioMarin Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TATT vs. BMRN - Profitability Comparison
TATT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Tat Techno reported a gross profit of 10.03M and revenue of 41.15M. Therefore, the gross margin over that period was 24.4%.
BMRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BioMarin Pharmaceutical Inc. reported a gross profit of 571.21M and revenue of 766.21M. Therefore, the gross margin over that period was 74.6%.
TATT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Tat Techno reported an operating income of 2.99M and revenue of 41.15M, resulting in an operating margin of 7.3%.
BMRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BioMarin Pharmaceutical Inc. reported an operating income of 129.64M and revenue of 766.21M, resulting in an operating margin of 16.9%.
TATT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Tat Techno reported a net income of 3.40M and revenue of 41.15M, resulting in a net margin of 8.3%.
BMRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BioMarin Pharmaceutical Inc. reported a net income of 105.53M and revenue of 766.21M, resulting in a net margin of 13.8%.
Frequently Asked Questions
TATT and BMRN have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TATT has higher volatility (25.05%) compared to BMRN (15.30%). In terms of maximum drawdown, TATT dropped -97.07% vs BMRN's -90.58%.
TATT currently has the higher Sharpe Ratio (0.99 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TATT and BMRN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer